| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Cabotegravir 200 mg/mL prolonged-release suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Product containing cabotegravir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only cabotegravir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Cabotegravir-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Product containing only cabotegravir in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Cabotegravir sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
|
| Product containing only cabotegravir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Cabotegravir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
| Cabotegravir (as cabotegravir sodium) 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cabotegravir (substance) |
Inferred relationship |
Some |
1 |
FHIR